Detalles de la búsqueda
1.
Patient factors influencing acute gluten reactions and cytokine release in treated coeliac disease.
BMC Med
; 18(1): 362, 2020 11 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33239013
2.
Linking Endogenous Factor Xa Activity, a Biologically Relevant Pharmacodynamic Marker, to Edoxaban Plasma Concentrations and Clinical Outcomes in the ENGAGE AF-TIMI 48 Trial.
Circulation
; 138(18): 1963-1973, 2018 10 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-29967197
3.
Edoxaban drug-drug interactions with ketoconazole, erythromycin, and cyclosporine.
Br J Clin Pharmacol
; 82(6): 1591-1600, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27530188
4.
Efficacy and safety of gluten peptide-based antigen-specific immunotherapy (Nexvax2) in adults with coeliac disease after bolus exposure to gluten (RESET CeD): an interim analysis of a terminated randomised, double-blind, placebo-controlled phase 2 study.
Lancet Gastroenterol Hepatol
; 8(5): 446-457, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36898393
5.
A Sensitive Whole Blood Assay Detects Antigen-Stimulated Cytokine Release From CD4+ T Cells and Facilitates Immunomonitoring in a Phase 2 Clinical Trial of Nexvax2 in Coeliac Disease.
Front Immunol
; 12: 661622, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34093551
6.
Masked bolus gluten challenge low in FODMAPs implicates nausea and vomiting as key symptoms associated with immune activation in treated coeliac disease.
Aliment Pharmacol Ther
; 51(2): 244-252, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31769533
7.
Use of an exposure-response model to aid early drug development of an oral sphingosine 1-phosphate receptor modulator.
J Clin Pharmacol
; 49(1): 50-62, 2009 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-18948412
8.
Randomised clinical trial: a placebo-controlled study of subcutaneous or intradermal NEXVAX2, an investigational immunomodulatory peptide therapy for coeliac disease.
Aliment Pharmacol Ther
; 50(5): 547-555, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31407810
9.
Elevated serum interleukin-2 after gluten correlates with symptoms and is a potential diagnostic biomarker for coeliac disease.
Aliment Pharmacol Ther
; 50(8): 901-910, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31483515
10.
Model-based development of a PPARgamma agonist, rivoglitazone, to aid dose selection and optimize clinical trial designs.
J Clin Pharmacol
; 48(12): 1420-9, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18936283
11.
Pain relief model for a COX-2 inhibitor in patients with postoperative dental pain.
Br J Clin Pharmacol
; 66(1): 60-70, 2008 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-18522627
12.
A randomized, double-blind, celecoxib- and placebo-controlled study of the effectiveness of CS-706 in acute postoperative dental pain.
Clin Ther
; 29(3): 399-412, 2007 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-17577461
13.
Pharmacokinetics and Pharmacodynamics of Edoxaban, a Non-Vitamin K Antagonist Oral Anticoagulant that Inhibits Clotting Factor Xa.
Clin Pharmacokinet
; 55(6): 641-55, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26620048
14.
Population pharmacokinetic modeling and simulation for assessing renal impairment effect on the pharmacokinetics of mirogabalin.
J Clin Pharmacol
; 56(2): 203-12, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26138993
15.
Exposure-response modeling of average daily pain score, and dizziness and somnolence, for mirogabalin (DS-5565) in patients with diabetic peripheral neuropathic pain.
J Clin Pharmacol
; 56(1): 67-77, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26073181
16.
Editorial: a non-dietary treatment for coeliac disease-two steps forward, one step back? Authors' reply.
Aliment Pharmacol Ther
; 50(8): 956-957, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31591779
17.
Safety and efficacy of colesevelam HCl in the treatment of elderly patients.
Drugs Aging
; 31(6): 461-70, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24777691
18.
Pharmacological modulation of peripheral T and B lymphocytes by a selective sphingosine 1-phosphate receptor-1 modulator.
J Clin Pharmacol
; 52(7): 996-1006, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21566200
19.
Pharmacological effects of CS-0777, a selective sphingosine 1-phosphate receptor-1 modulator: results from a 12-week, open-label pilot study in multiple sclerosis patients.
J Neuroimmunol
; 246(1-2): 100-7, 2012 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22465063
20.
Diabetic macular edema: correlations with available diabetes therapies--evidence across a qualitative review of published literature from MEDLINE and EMBASE.
Drug Saf
; 33(8): 643-52, 2010 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20635822